Retrograde pyelography predicts retrograde ureteral stenting failure and reduces unnecessary stenting trials in patients with advanced non-urological malignant ureteral obstruction.

about

Retrograde pyelography predicts retrograde ureteral stenting failure and reduces unnecessary stenting trials in patients with advanced non-urological malignant ureteral obstruction.

Item

http://www.wikidata.org/entity/Q42361540

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Retrograde pyelography predict ...... alignant ureteral obstruction.

@en

Retrograde pyelography predict ...... alignant ureteral obstruction.

@nl

type

Item

label

Retrograde pyelography predict ...... alignant ureteral obstruction.

@en

Retrograde pyelography predict ...... alignant ureteral obstruction.

@nl

prefLabel

Retrograde pyelography predict ...... alignant ureteral obstruction.

@en

Retrograde pyelography predict ...... alignant ureteral obstruction.

@nl

P1476

Retrograde pyelography predict ...... alignant ureteral obstruction.

@en

P2093

Boram Park

http://www.w3.org/2001/XMLSchema#string

Ho Kyung Seo

http://www.w3.org/2001/XMLSchema#string

Jae Young Joung

http://www.w3.org/2001/XMLSchema#string

Jinsoo Chung

http://www.w3.org/2001/XMLSchema#string

Jungnam Joo

http://www.w3.org/2001/XMLSchema#string

Kang Hyun Lee

http://www.w3.org/2001/XMLSchema#string

Sung Han Kim

http://www.w3.org/2001/XMLSchema#string

P2860

National rates and risk factors for stent failure after successful insertion in patients with obstructed, infected upper tract stones.

15-year experience with the management of extrinsic ureteral obstruction with indwelling ureteral stents.

Stent-change therapy in advanced malignancies with ureteral obstruction.

Predicting the failure of retrograde ureteral stent insertion for managing malignant ureteral obstruction in outpatients.

Predicting factors for stent failure-free survival in patients with a malignant ureteral obstruction managed with ureteral stents.

Management of ureteral obstruction due to advanced malignancy: optimizing therapeutic and palliative outcomes.

Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment.

Palliation of obstructive nephropathy due to malignancy.

Outcome of retrograde ureteric stenting as a urinary drainage procedure in ureteric obstruction related to malignant lesions.

Multicenter experience with metallic ureteral stents for malignant and chronic benign ureteral obstruction.

P304

e0184965

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0184965

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28931043

http://www.w3.org/2001/XMLSchema#string

P932

5607161

http://www.w3.org/2001/XMLSchema#string